Tissue-Engineered Organs

Steve J. Hodges, Anthony Atala

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Human organs are exposed to a variety of possible injuries from the time the fetus develops. Individuals may suffer from many conditions that may lead to organ damage or loss and necessitate eventual reconstruction or replacement. In most cases, the replacement of lost or deficient tissues with functionally equivalent autologous tissues would improve the outcome for patients immensely. Tissue-engineering therapies have been developed in order to achieve this goal. The development of functional organ systems from the building blocks of cells, scaffolding, and growth factors is a Herculean task, however, as evidenced by the few successful tissue-engineering technologies currently in clinical use. There have been successes, however, as evidenced by functioning autologous bioengineered tissues that have been implanted in humans - including trachea, blood vessels, pulmonary valves, endothelialized vascular stents, and urinary bladder. An examination of the building blocks of tissue-engineering strategies, as well the successful applications of these techniques in human clinical applications, provides an insight into the difficulties facing scientists as they seek to develop more complex bioengineered organs.

Original languageEnglish
Title of host publicationPrinciples of Tissue Engineering: Fourth Edition
PublisherElsevier Inc.
Pages1765-1777
Number of pages13
ISBN (Print)9780123983589
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Tissue Engineering
Tissue engineering
Tissue
Blood Vessels
Pulmonary Valve
Stents
Engineering technology
Blood vessels
Cell- and Tissue-Based Therapy
Trachea
Intercellular Signaling Peptides and Proteins
Urinary Bladder
Fetus
Technology
Wounds and Injuries

Keywords

  • Acellular matrix
  • Bladder
  • Cloning
  • Donor tissue
  • Growth factor
  • Implant
  • Kidney
  • Regenerative medicine
  • Scaffolding
  • Skin
  • Stem cells
  • Tissue engineering

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hodges, S. J., & Atala, A. (2013). Tissue-Engineered Organs. In Principles of Tissue Engineering: Fourth Edition (pp. 1765-1777). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-398358-9.00085-9

Tissue-Engineered Organs. / Hodges, Steve J.; Atala, Anthony.

Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., 2013. p. 1765-1777.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hodges, SJ & Atala, A 2013, Tissue-Engineered Organs. in Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., pp. 1765-1777. https://doi.org/10.1016/B978-0-12-398358-9.00085-9
Hodges SJ, Atala A. Tissue-Engineered Organs. In Principles of Tissue Engineering: Fourth Edition. Elsevier Inc. 2013. p. 1765-1777 https://doi.org/10.1016/B978-0-12-398358-9.00085-9
Hodges, Steve J. ; Atala, Anthony. / Tissue-Engineered Organs. Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., 2013. pp. 1765-1777
@inbook{bb3806449d0d48e7a745380fe92fc211,
title = "Tissue-Engineered Organs",
abstract = "Human organs are exposed to a variety of possible injuries from the time the fetus develops. Individuals may suffer from many conditions that may lead to organ damage or loss and necessitate eventual reconstruction or replacement. In most cases, the replacement of lost or deficient tissues with functionally equivalent autologous tissues would improve the outcome for patients immensely. Tissue-engineering therapies have been developed in order to achieve this goal. The development of functional organ systems from the building blocks of cells, scaffolding, and growth factors is a Herculean task, however, as evidenced by the few successful tissue-engineering technologies currently in clinical use. There have been successes, however, as evidenced by functioning autologous bioengineered tissues that have been implanted in humans - including trachea, blood vessels, pulmonary valves, endothelialized vascular stents, and urinary bladder. An examination of the building blocks of tissue-engineering strategies, as well the successful applications of these techniques in human clinical applications, provides an insight into the difficulties facing scientists as they seek to develop more complex bioengineered organs.",
keywords = "Acellular matrix, Bladder, Cloning, Donor tissue, Growth factor, Implant, Kidney, Regenerative medicine, Scaffolding, Skin, Stem cells, Tissue engineering",
author = "Hodges, {Steve J.} and Anthony Atala",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/B978-0-12-398358-9.00085-9",
language = "English",
isbn = "9780123983589",
pages = "1765--1777",
booktitle = "Principles of Tissue Engineering: Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Tissue-Engineered Organs

AU - Hodges, Steve J.

AU - Atala, Anthony

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Human organs are exposed to a variety of possible injuries from the time the fetus develops. Individuals may suffer from many conditions that may lead to organ damage or loss and necessitate eventual reconstruction or replacement. In most cases, the replacement of lost or deficient tissues with functionally equivalent autologous tissues would improve the outcome for patients immensely. Tissue-engineering therapies have been developed in order to achieve this goal. The development of functional organ systems from the building blocks of cells, scaffolding, and growth factors is a Herculean task, however, as evidenced by the few successful tissue-engineering technologies currently in clinical use. There have been successes, however, as evidenced by functioning autologous bioengineered tissues that have been implanted in humans - including trachea, blood vessels, pulmonary valves, endothelialized vascular stents, and urinary bladder. An examination of the building blocks of tissue-engineering strategies, as well the successful applications of these techniques in human clinical applications, provides an insight into the difficulties facing scientists as they seek to develop more complex bioengineered organs.

AB - Human organs are exposed to a variety of possible injuries from the time the fetus develops. Individuals may suffer from many conditions that may lead to organ damage or loss and necessitate eventual reconstruction or replacement. In most cases, the replacement of lost or deficient tissues with functionally equivalent autologous tissues would improve the outcome for patients immensely. Tissue-engineering therapies have been developed in order to achieve this goal. The development of functional organ systems from the building blocks of cells, scaffolding, and growth factors is a Herculean task, however, as evidenced by the few successful tissue-engineering technologies currently in clinical use. There have been successes, however, as evidenced by functioning autologous bioengineered tissues that have been implanted in humans - including trachea, blood vessels, pulmonary valves, endothelialized vascular stents, and urinary bladder. An examination of the building blocks of tissue-engineering strategies, as well the successful applications of these techniques in human clinical applications, provides an insight into the difficulties facing scientists as they seek to develop more complex bioengineered organs.

KW - Acellular matrix

KW - Bladder

KW - Cloning

KW - Donor tissue

KW - Growth factor

KW - Implant

KW - Kidney

KW - Regenerative medicine

KW - Scaffolding

KW - Skin

KW - Stem cells

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84903224567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903224567&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-398358-9.00085-9

DO - 10.1016/B978-0-12-398358-9.00085-9

M3 - Chapter

AN - SCOPUS:84903224567

SN - 9780123983589

SP - 1765

EP - 1777

BT - Principles of Tissue Engineering: Fourth Edition

PB - Elsevier Inc.

ER -